Beyond Air To Participate In The 2026 Cantor Global Healthcare Conference

(MENAFN- GlobeNewsWire - Nasdaq) GARDEN CITY, N.Y., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve patients' lives, today announced that its management team will participate in the 2026 Cantor Global Healthcare Conference, which is being held at the Waldorf Astoria New York, New York on September 9-11, 2026.

Fireside Chat Details:
Date: Thursday, September 10^th
Time: 3:55 PM EDT
Webcast Link: A live webcast of the fireside chat will be available on the Events section of the Company's website, . Following the live presentation, a replay of the webcast will be available on the Company's website for 90 days.

If you are interested in requesting a one-on-one meeting at the conference, please contact your Cantor representative to schedule accordingly.

About Beyond Air, Inc.
Beyond Air is a commercial-stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. The Company has received FDA approval and CE Mark for its first system, LungFit PH, for the treatment of term and near-term neonates with hypoxic respiratory failure. For more information, visit

CONTACTS:

Corey Davis, Ph.D.
LifeSci Advisors, LLC
...
(212) 915-2577

MENAFN02092026004107003653ID1111612002